Status:
UNKNOWN
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
Ludwig-Maximilians - University of Munich
Conditions:
Childhood Cancer
Eligibility:
All Genders
4-18 years
Brief Summary
Reduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients. Increased muscle strength is ...
Eligibility Criteria
Inclusion
- Children and adolescents aged 4-18 years
- At the end of acute treament for leukemia or non-Hodgkin lymphoma
- Diagnosed and/or treated at the Dr. von Hauner Children's Hospital, University of Munich
- Informed consent as documented by signature
Exclusion
- Medical contraindication to perform this unique test battery (e.g., acute bleeding risk, pain, nausea, acute orthopedic impairments)
- Inability to follow study procedures (e.g., language problems, mental retardation)
Key Trial Info
Start Date :
April 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05235633
Start Date
April 19 2022
End Date
December 31 2024
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kinderklinik München Schwabing, TUM School of Medicine, Department of Paediatrics and Children's Cancer Research Center, Technical University of Munich, Germany
Munich, Germany, 80804